Chairman becomes major investor in company that wants to prevent Alzheimer's disease using light therapy
The Danish-US company Optoceutics has gained a large investment from board chairman Rasmus Just, who is now considered a major investor in the company, which is attempting to prevent Alzheimer's disease using light therapy.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.